0
0
5/22/23 at 3:00pm
Organization
CNBC
Author
Annika Kim Constantino
46 words
0
Comments
Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection of Ozempic, made by Novo Nordisk.
You are the first to view
https://www.cnbc.com/2023/05/22/pfizer-weight-loss-drug-compares-to-ozempic-by-novo-nordisk.html
Create an account
or login to join the discussion